MeSH term
Frequency | Condition_Probility | Adult | 4 | 0.0 |
Humans | 67 | 0.0 |
Male | 11 | 0.0 |
Middle Aged | 3 | 0.0 |
Reference Values | 2 | 0.0 |
Aged | 3 | 0.0 |
Time Factors | 3 | 0.0 |
*Drosophila Proteins | 16 | 1.0 |
Macrophages/metabolism | 4 | 1.0 |
Membrane Glycoproteins/genetics/*metabolism | 6 | 3.0 |
Monocytes/metabolism | 2 | 0.0 |
RNA, Messenger/metabolism | 6 | 0.0 |
Receptors, Cell Surface/genetics/*metabolism | 5 | 3.0 |
Research Support, Non-U.S. Gov't | 48 | 0.0 |
Up-Regulation | 4 | 0.0 |
Animals | 37 | 0.0 |
Cell Line | 20 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Interferon-beta/metabolism | 2 | 10.0 |
Mice | 23 | 0.0 |
Mice, Inbred BALB C | 4 | 0.0 |
NF-kappa B/metabolism | 6 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
Signal Transduction | 14 | 0.0 |
Transfection | 8 | 0.0 |
Luciferases/genetics | 2 | 0.0 |
RNA Interference | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 26 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Cells, Cultured | 23 | 0.0 |
Membrane Glycoproteins/*genetics | 6 | 1.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Receptors, Cell Surface/*genetics | 6 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Antigens, Differentiation/metabolism | 3 | 2.0 |
Cytokines/biosynthesis | 7 | 1.0 |
Lymphocyte Activation | 3 | 0.0 |
Membrane Glycoproteins/*metabolism | 8 | 1.0 |
Molecular Sequence Data | 8 | 0.0 |
NF-kappa B/*metabolism | 4 | 0.0 |
Receptors, Cell Surface/*metabolism | 9 | 1.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Adaptor Proteins, Vesicular Transport/genetics/*metabolism | 2 | 40.0 |
Signal Transduction/*physiology | 3 | 0.0 |
TNF Receptor-Associated Factor 6 | 4 | 3.0 |
Female | 14 | 0.0 |
Glycoproteins/*immunology | 2 | 2.0 |
Blotting, Western | 4 | 0.0 |
Comparative Study | 9 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Cell Differentiation/immunology | 4 | 1.0 |
Cell Membrane/immunology/metabolism | 2 | 1.0 |
Lipopolysaccharides/pharmacology | 9 | 0.0 |
Protein Kinases/metabolism | 4 | 0.0 |
RNA, Messenger/biosynthesis | 5 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Membrane Glycoproteins/*immunology | 5 | 2.0 |
Receptors, Cell Surface/*immunology | 5 | 6.0 |
Signal Transduction/*immunology | 5 | 1.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Antigens, Differentiation/immunology | 2 | 1.0 |
Gene Expression | 3 | 0.0 |
Immunity, Natural | 2 | 0.0 |
Poly I-C/*pharmacology | 2 | 18.0 |
Ligands | 9 | 0.0 |
Flagellin/pharmacology | 3 | 42.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Zymosan/pharmacology | 2 | 2.0 |
Interferon Type II/immunology | 2 | 2.0 |
Membrane Glycoproteins/immunology | 3 | 1.0 |
Receptors, Cell Surface/immunology | 4 | 11.0 |
T-Lymphocytes/*immunology | 2 | 0.0 |
Membrane Glycoproteins/*physiology | 5 | 1.0 |
Receptors, Cell Surface/*physiology | 6 | 2.0 |
Adaptor Proteins, Vesicular Transport/*immunology | 2 | 66.0 |
Receptors, Immunologic/immunology | 2 | 1.0 |
Hela Cells | 3 | 0.0 |
Receptors, Immunologic/metabolism | 3 | 1.0 |
*Gene Expression Regulation | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Child | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Models, Biological | 3 | 0.0 |
Mice, Inbred C57BL | 8 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
NF-kappa B/*physiology | 3 | 3.0 |
Sequence Alignment | 2 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Peptidoglycan/pharmacology | 2 | 12.0 |
Poly I-C/pharmacology | 3 | 12.0 |
Mice, Knockout | 4 | 0.0 |
Enzyme Activation | 3 | 0.0 |
Immunoprecipitation | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Virulence | 2 | 0.0 |
Adaptor Proteins, Vesicular Transport/*physiology | 2 | 40.0 |
Mutation | 2 | 0.0 |
RNA, Double-Stranded/pharmacology | 3 | 42.0 |
Signal Transduction/immunology | 2 | 0.0 |
*Response Elements | 2 | 3.0 |
Body Mass Index | 2 | 0.0 |
Energy Intake | 2 | 1.0 |
Exercise/*physiology | 2 | 0.0 |
*Leisure Activities | 2 | 6.0 |
Motor Activity/physiology | 2 | 2.0 |
Obesity/epidemiology/*etiology | 2 | 6.0 |
Self Disclosure | 2 | 6.0 |
Television | 2 | 5.0 |
CpG Islands/immunology | 2 | 15.0 |
Interferon-alpha/biosynthesis | 2 | 8.0 |
*Adaptor Proteins, Signal Transducing | 3 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Lipopolysaccharides/metabolism | 2 | 1.0 |
Precipitin Tests | 3 | 0.0 |
Active Transport, Cell Nucleus | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Proteins/metabolism | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Membrane Glycoproteins/biosynthesis/genetics | 2 | 4.0 |
Receptors, Cell Surface/biosynthesis/genetics | 2 | 9.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
Interferon-beta/antagonists & inhibitors/*genetics/metabolism | 2 | 100.0 |
Promoter Regions (Genetics)/*immunology | 2 | 4.0 |
